RxDoctor Payments Data

Jonathan Garino, MD

Orthopaedic Surgery · Malvern, PANPI 1952339731

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $3,788,557 of the $3,790,603 with a category attached, or 99.9%. Smith+Nephew accounts for 100.0% of it on its own, with 23 other manufacturers making up the rest. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,790,603in general payments, 2019–2025

Across 94 payments — averaging $40,326 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$3.8M
  • Stryker$421
  • Zimmer Biomet$311
  • Heraeus Medical, LLC.$226
  • Davol Inc.$184
  • UOC USA Inc$138
  • plus $603 from 18 others
$39,205in research payments, 2019–2025

Across 12 payments — averaging $3267.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$39K

What the payments were for

  • Royalty or licence$3,788,557100%
  • Food & beverage$2,0460%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,790,603 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$444,554
Medicare patients
623
Services billed
4,077

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium14$1,419
Methylprednisolone174$1,220
Meloxicam397$1,016
Oxycodone Hcl159$809
Ondansetron OdtOndansetron101$801
Doxycycline Hyclate98$685
Tramadol Hcl170$477
Pregabalin23$398
Celecoxib17$391
Cephalexin80$233
Amoxicillin100$232
Prednisone44$164
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen42$81
Clindamycin Hcl27$60
Gabapentin11$38

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Malvern

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →